{"href":"http://player.captivate.fm/services/oembed?url=http%3A%2F%2Fplayer.captivate.fm%2Fepisode%2Feba5b9bc-45be-49c7-aef9-50e9f4a78ea6","version":"1.0","provider_name":"Captivate.FM","provider_url":"https://www.captivate.fm","width":600,"height":200,"type":"rich","html":"<iframe style=\"width: 100%; height: 200px;\" title=\" Novel Agents, Approaches and Strategies in the Management of Higher-Risk Myelodysplastic Syndromes\" frameborder=\"0\" scrolling=\"no\" allow=\"clipboard-write\" seamless src=\"http://player.captivate.fm/episode/eba5b9bc-45be-49c7-aef9-50e9f4a78ea6\"></iframe>","title":" Novel Agents, Approaches and Strategies in the Management of Higher-Risk Myelodysplastic Syndromes","description":"\n        <p>Featuring perspectives from Dr Guillermo Garcia-Manero and Dr David Sallman.</p>\n\n<p>CME information and select publications <a href=\"https://www.researchtopractice.com/InsidetheIssue2023/MDS\" rel=\"nofollow\">here</a></p>\n      ","thumbnail_width":300,"thumbnail_height":300,"thumbnail_url":"https://artwork.captivate.fm/92d64c91-0535-428b-8546-539f2bd5935c/cover.jpg"}